posted on 2021-03-12, 16:06authored byJCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard, P Zhang, ESH Lau, B Eliasson, APS Kong, M Ezzati, CA Aguilar-Salinas, M McGill, NS Levitt, G Ning, WY So, J Adams, P Bracco, NG Forouhi, GA Gregory, J Guo, X Hua, EL Klatman, DJ Magliano, BP Ng, D Ogilvie, J Panter, M Pavkov, H Shao, N Unwin, M White, C Wou, RCW Ma, MI Schmidt, A Ramachandran, Y Seino, PH Bennett, B Oldenburg, JJ Gagliardino, AOY Luk, PM Clarke, GD Ogle, MJ Davies, RR Holman, EW Gregg
In this Lancet Commission on diabetes, which embodies 4 years of extensive work on data curation, synthesis, and modelling, we urge policy makers, payers, and planners to collectively change the ecosystem, build capacity, and improve the clinical practice environment. Such actions will enable practitioners to systematically collect data during routine practice and to use these data effectively to diagnose early, stratify risks, define needs, improve care, evaluate solutions, and drive changes at patient, system, and policy levels to prevent and control diabetes and other non-communicable diseases. Emerging evidence regarding the possible damaging effects of severe acute respiratory syndrome coronavirus 2 on pancreatic islets implies the potential worsening of the COVID-19 pandemic and the diabetes epidemic, adding to the urgency of these collective actions.
History
Citation
The Lancet, Volume 396, Issue 10267, 19 December 2020–1 January 2021, Pages 2019-2082
Author affiliation
Diabetes Research Centre, College of Life Sciences